Next-Generation Sequencing (NGS) In Precision Medicine Sector Forecast Shows Robust Momentum, Climbing to $14.05 Billion With 16.9% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What are the forecasted starting (2026) and ending (2030) market sizes for the Next-Generation Sequencing (NGS) In Precision Medicine Market?
The market for next-generation sequencing (ngs) in precision medicine has experienced rapid expansion in recent years. It is anticipated to increase from $6.42 billion in 2025 to $7.52 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.2%. This historical growth can be ascribed to several factors, including the advancement of high-throughput sequencers, increasing recognition of personalized medicine, expanding genomic research, the wider availability of bioinformatics software, and the integration of precision medicine into clinical trials.
The next-generation sequencing (ngs) in precision medicine market is anticipated to experience significant expansion in the coming years. This market is projected to reach $14.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.9%. Factors contributing to this growth during the forecast period include technological strides in sequencing instruments, the incorporation of AI into genomics, an increase in cloud-based sequencing services, rising partnerships between pharmaceutical and biotechnology firms, and the broader adoption of precision medicine in developing areas. Key trends expected over the forecast period encompass AI-driven genomic analysis, cloud-based sequencing offerings, the spread of personalized medicine, enhanced automation in sequencing processes, and real-time interpretation of genomic data.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28280&type=smp
What Drivers Are Supporting Technological Adoption In The Next-Generation Sequencing (NGS) In Precision Medicine Market?
The increasing occurrence of genetic disorders is anticipated to stimulate the expansion of the next-generation sequencing (NGS) in precision medicine market moving forward. Genetic disorders are conditions or illnesses stemming from anomalies in an individual’s DNA, which can be inherited or acquired through mutations. The prevalence of genetic disorders is growing as advancements in diagnostic technologies, such as genetic screening and next-generation sequencing, enable medical professionals to identify previously undetected cases, thus leading to a higher reported incidence. Next-generation sequencing in precision medicine assists in discovering genetic mutations, facilitating accurate diagnosis, customized treatment, and prompt intervention for genetic disorders. As an illustration, in May 2024, the National Health Service, a UK-based government department, stated that approximately 17,000 people in England live with sickle cell disease, an inherited blood disorder, with roughly 250 new cases diagnosed each year. Hence, the increasing incidence of genetic disorders is propelling the growth of the next-generation sequencing (NGS) in precision medicine market.
Which Segments Are Contributing To The Growth Of The Next-Generation Sequencing (NGS) In Precision Medicine Market?
The next-generation sequencing (ngs) in precision medicine market covered in this report is segmented –
1) By Product And Service: Sequencing Instruments, Consumables And Reagents, Library Preparation Kits, Bioinformatics Software, Next-Generation Sequencing (NGS) Services
2) By Technology: Whole Genome Sequencing (WGS), Whole Exome Sequencing (Wes), Targeted Sequencing, Ribonucleic Acid (RNA) Sequencing, Single-Cell Sequencing
3) By Application: Oncology, Infectious Disease, Rare And Inherited Disorders, Prenatal And Reproductive Health, Pharmacogenomics
4) By End Use: Hospitals And Clinics, Academic And Research Institutions, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations (CROs)
Subsegments:
1) By Sequencing Instruments: Benchtop Sequencers, High Throughput Sequencers
2) By Consumables And Reagents: Sequencing Reagents, Sequencing Chips, Flow Cells, Sample Preparation Reagents
3) By Library Preparation Kits: Deoxyribonucleic Acid (DNA) Library Preparation Kits, Ribonucleic Acid (RNA) Library Preparation Kits, Whole Genome Amplification Kits, Target Enrichment Kits
4) By Bioinformatics Software: Data Analysis Software, Data Management Software, Sequence Alignment Software, Variant Calling Software
5) By Next-Generation Sequencing Services: Whole Genome Sequencing Services, Whole Exome Sequencing Services, Targeted Sequencing Services, Ribonucleic Acid (RNA) Sequencing Services, Epigenomic Sequencing Services
What Trends Are Driving The Growth Trajectory Of The Next-Generation Sequencing (NGS) In Precision Medicine Market?
Leading firms within the next-generation sequencing (NGS) in precision medicine market are prioritizing the creation of novel solutions, including multimodal DNA and RNA library kits, with the aim of boosting the effectiveness and precision of genomic analyses. Specifically, a multimodal DNA and RNA library kit refers to a laboratory tool that facilitates the concurrent preparation of sequencing libraries from both DNA and RNA within a unified process, thereby allowing for a thorough examination of a sample’s genome and transcriptome. As an illustration, in May 2024, Qiagen N.V., a Germany-based company known for its sample and assay technologies in molecular diagnostics, introduced the QIAseq Multimodal DNA and RNA Library Kit. This next-generation sequencing offering streamlines DNA and RNA library preparation from a single sample, thereby promoting multiomic investigations and propelling advancements in precision medicine. The kit supports comprehensive whole genome and whole transcriptome sequencing, along with subsequent target enrichment. It aids multiomic research by integrating optimized chemical processes for both DNA and RNA concurrently. Furthermore, it mitigates the requirement for substantial sample volumes and the labor-intensive protocols characteristic of conventional, distinct DNA and RNA workflows. By improving the efficiency of multiomic research, this kit contributes to the progression of precision medicine, leading to superior biomarker identification and a deeper comprehension of diseases, particularly within the field of cancer research.
Who Are The Major Companies Operating In The Next-Generation Sequencing (NGS) In Precision Medicine Market?
Major companies operating in the next-generation sequencing (ngs) in precision medicine market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Natera Inc., Tempus Labs Inc., 10x Genomics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Fulgent Genetics Inc., Twist Bioscience Corporation, Pacific Biosciences of California Inc., Macrogen Inc., Ultima Genomics Inc., Personalis Inc., Element Biosciences Inc., Genomenon Inc., Strand Life Sciences Pvt. Ltd., Singular Genomics Systems Inc.
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Next-Generation Sequencing (NGS) In Precision Medicine Market?
North America was the largest region in the next-generation sequencing (NGS) in precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing (ngs) in precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Next-Generation Sequencing (NGS) In Precision Medicine Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28280&type=smp
Browse Through More Reports Similar to the Global Next-Generation Sequencing (NGS) In Precision Medicine Market 2026, By The Business Research Company
Ngs Based Rna Sequencing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Next Generation Sequencing Market 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Clinical Oncology Next Generation Sequencing Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
